How to Get Tadalafil (Generic) in New Jersey: Telehealth, Prescription, and Pharmacy Guide

How to Get Tadalafil (Generic) in New Jersey
At a glance
- Drug / tadalafil 2.5 mg, 5 mg, 10 mg, and 20 mg oral tablets (generic of Cialis)
- FDA approval / originally approved 2003; generic entry November 2017
- NJ telehealth prescribing / fully legal for tadalafil under NJ telemedicine statute
- Who prescribes / MD, DO, NP (with prescriptive authority), PA (with supervising-physician agreement)
- NJ Medicaid / covered with prior authorization for ED and BPH
- 503A compounding / NJ Board of Pharmacy licenses 503A facilities to dispense tadalafil 2.5 to 20 mg
- Typical delivery time / 2 to 5 business days from NJ-licensed telehealth platforms
- On-demand dose / 10 mg taken 30 minutes before activity, adjustable to 20 mg
- Daily dose / 2.5 mg or 5 mg once daily for continuous coverage or BPH
- Half-life / 17.5 hours, the longest among PDE5 inhibitors
NJ Telehealth Prescribing Rules for Tadalafil
New Jersey permits telehealth prescribing of tadalafil without an in-person visit, provided the prescriber holds an active NJ medical license and establishes a valid provider-patient relationship during the encounter. The state updated its telemedicine statute (P.L. 2017, c.117) to allow synchronous audio-video consultations for prescription medications, including PDE5 inhibitors like tadalafil 1.
A telehealth evaluation for tadalafil typically takes 10 to 20 minutes. The prescriber reviews cardiovascular risk factors, current medications (particularly nitrates and alpha-blockers), and baseline blood pressure. The American Urological Association (AUA) recommends PDE5 inhibitors as first-line pharmacotherapy for ED 2. Tadalafil's 17.5-hour half-life gives it the widest dosing window among approved PDE5 inhibitors, making it the most frequently prescribed option for daily-use regimens 3.
NJ does not require a separate controlled-substance waiver for tadalafil because it is not a scheduled drug under federal or state law. Any NJ-licensed prescriber with active DEA registration (required for general prescriptive authority) can prescribe it via telehealth after documenting the clinical rationale in the medical record 4.
Who Can Prescribe Tadalafil in New Jersey
Four provider types hold independent or supervised prescriptive authority for tadalafil in NJ: physicians (MD/DO), nurse practitioners, physician assistants, and urologists practicing within their specialty scope. NPs in New Jersey gained full practice authority in 2022, meaning they can prescribe tadalafil without a collaborative physician agreement after completing the required supervised clinical hours 5.
PAs prescribe under a joint protocol with a supervising physician, but this does not limit the medications available to them. Tadalafil falls within the standard formulary for any PA practicing in urology, internal medicine, or family medicine 6. The prescriber must document the indication (ED, BPH, or both), rule out contraindications like concurrent nitrate therapy, and verify that the patient's resting blood pressure exceeds 90/60 mmHg 7.
Specialists and generalists prescribe tadalafil at comparable rates. A 2019 analysis of Medicare Part D claims found that urologists wrote 34% of PDE5 inhibitor prescriptions while primary care physicians accounted for 52% 8.
What Labs Are Needed Before Starting Tadalafil
No mandatory lab panel is required before prescribing tadalafil for most patients. The AUA guidelines state that a focused sexual-health history and cardiovascular risk assessment are sufficient for otherwise healthy men 2. Many telehealth platforms and NJ prescribers request baseline labs when the clinical picture suggests an underlying condition contributing to ED.
Commonly ordered labs include fasting glucose or HbA1c (to screen for diabetes, which affects 50% of men with ED), total and free testosterone, a lipid panel, and a comprehensive metabolic panel 9. The Endocrine Society recommends measuring morning total testosterone in men with ED who also report low libido, fatigue, or reduced muscle mass 10.
If a man under 40 presents with ED and no obvious risk factors, the European Association of Urology recommends additional vascular workup including penile Doppler ultrasound to rule out early atherosclerotic disease 11. For BPH-only indications, a PSA test and digital rectal exam are standard before initiating tadalafil 5 mg daily per AUA guidelines 12.
Tadalafil Dosing: Daily vs. On-Demand
The FDA-approved dosing splits into two protocols. On-demand dosing starts at 10 mg taken at least 30 minutes before sexual activity, adjustable to 20 mg or down to 5 mg based on efficacy and tolerability. Daily dosing uses 2.5 mg or 5 mg taken at the same time each day regardless of planned activity 4.
Brock et al. Demonstrated in their key trial (N=1,112) that tadalafil 20 mg improved erectile function scores by 7.9 points on the IIEF compared to 1.2 points for placebo (P<0.001) 3. Daily 5 mg tadalafil was later shown to produce IIEF improvements of 6.0 points over placebo in the LVHJ study, with the additional benefit of reducing International Prostate Symptom Scores by 4.8 points 13.
For men with both ED and BPH, the dual-indication approach is cost-effective. A single daily 5 mg tablet addresses both conditions. The FDA approved this dual indication in 2011, making tadalafil the only PDE5 inhibitor with a BPH label 14. NJ prescribers frequently choose the daily regimen for patients who prefer spontaneity over timed dosing. Tadalafil reaches steady-state plasma concentration within 5 days of daily administration 15.
New Jersey Pharmacy Options: Retail and 503A Compounding
Generic tadalafil is stocked at all major NJ retail chains (CVS, Walgreens, Rite Aid, Costco). Cash prices for 30 tablets of generic tadalafil 5 mg range from $15 to $45 depending on the pharmacy, a sharp drop from the $400-plus monthly cost of brand Cialis before patent expiration in November 2017 16.
NJ-licensed 503A compounding pharmacies can also dispense tadalafil. These facilities operate under Section 503A of the Federal Food, Drug, and Cosmetic Act, which requires a patient-specific prescription and compliance with USP compounding standards 17. The NJ Board of Pharmacy inspects and licenses all 503A facilities operating within or shipping into the state.
Compounding pharmacies fill a particular niche for combination formulations (such as tadalafil combined with oxytocin nasal spray) or for patients requiring non-standard doses. However, for standard 2.5, 5, 10, and 20 mg tablets, FDA-approved generics from manufacturers like Teva, Mylan, and Aurobindo are bioequivalent to brand Cialis and generally preferred by insurers 16.
NJ Medicaid Coverage and Prior Authorization
New Jersey Medicaid covers generic tadalafil for both ED and BPH indications, but a prior authorization (PA) is required. The PA process verifies the diagnosis, confirms the absence of contraindications, and documents that the patient has not responded adequately to lifestyle modifications alone 18.
The documentation package for a NJ Medicaid PA typically includes the prescriber's clinical notes, the specific ICD-10 code (N52.9 for ED, N40.1 for BPH with LUTS), and lab results if they were obtained. Processing takes 24 to 72 hours for standard requests. NJ FamilyCare (the state's Medicaid managed-care program) contracts with several managed-care organizations that each maintain their own formulary tiers, but all are required to cover at least one generic PDE5 inhibitor per CMS guidelines 19.
Commercial insurers in NJ vary widely. Some cover tadalafil on Tier 2 with a $10 to $30 copay. Others restrict coverage to the daily 5 mg dose for BPH only and exclude the ED indication. Patients denied coverage can use manufacturer discount cards or GoodRx-type coupons, which bring 30-tablet supplies of generic tadalafil below $20 at many NJ pharmacies.
Safety, Contraindications, and Drug Interactions
Tadalafil is contraindicated with any form of nitrate therapy. The combination can produce severe hypotension. A minimum 48-hour washout is recommended between tadalafil and nitrates because of tadalafil's prolonged half-life 4. Alpha-blockers like tamsulosin require caution. The FDA label recommends starting tadalafil at 2.5 mg when co-prescribed with alpha-blockers and monitoring for orthostatic hypotension 20.
The most common side effects in clinical trials were headache (15%), dyspepsia (10%), back pain (6%), myalgia (5%), nasal congestion (4%), and flushing (3%) 3. Back pain and myalgia are more prevalent with tadalafil than with sildenafil or vardenafil, likely due to PDE11 cross-reactivity 21.
Serious adverse events are rare. The incidence of priapism (erection lasting >4 hours) was fewer than 1 in 10 to 000 in post-marketing surveillance 22. Non-arteritic anterior ischemic optic neuropathy (NAION) has been reported with all PDE5 inhibitors, but a causal relationship has not been established; the FDA added a warning label in 2005 based on spontaneous reports 23.
Tadalafil is metabolized primarily by CYP3A4. Strong CYP3A4 inhibitors like ketoconazole and ritonavir increase tadalafil exposure, so the maximum recommended dose drops to 10 mg every 72 hours in patients taking these medications 4. Grapefruit juice has a mild inhibitory effect and is generally not clinically significant at normal intake volumes.
Transferring a Tadalafil Prescription to New Jersey
Patients relocating to NJ can transfer an existing tadalafil prescription from any U.S. State. The receiving NJ pharmacy contacts the originating pharmacy to verify the prescription details, remaining refills, and prescriber information. NJ Board of Pharmacy regulations allow inter-state prescription transfers for non-controlled medications without additional prescriber authorization 24.
The process takes 1 to 3 business days. Electronic prescribing (e-prescribing) speeds this up considerably. Since 2021, NJ has required e-prescribing for all new prescriptions under the Electronic Prescribing Act, which reduces transcription errors and accelerates pharmacy processing 25.
If the prescription has expired (more than 12 months old in NJ), a new clinical evaluation is required. Many telehealth platforms complete renewal visits in under 15 minutes, issuing a fresh e-prescription to the patient's preferred NJ pharmacy the same day.
How Long Until Tadalafil Arrives in New Jersey
Fulfillment timelines depend on the dispensing model. Brick-and-mortar NJ pharmacies fill generic tadalafil prescriptions within 1 to 4 hours if the drug is in stock, which it nearly always is given the volume of generic production. Mail-order pharmacies operating under NJ Board of Pharmacy licenses typically ship within 24 hours, with 2 to 5 business day delivery via USPS or UPS.
Telehealth-to-doorstep platforms (where the consultation and dispensing happen through one provider) quote 3 to 7 days for first-time patients because of the initial clinical evaluation, identity verification, and pharmacy processing steps. Refills are faster, often arriving within 2 to 3 business days. Expedited shipping options can cut delivery to 1 to 2 days at an additional cost, typically $5 to $15 26.
Patients using NJ 503A compounding pharmacies may experience slightly longer timelines (5 to 10 business days) because each prescription is compounded individually rather than pulled from pre-manufactured stock.
Clinical Efficacy: What the Trial Data Shows
The Phase III program for tadalafil enrolled over 4,000 men across multiple randomized controlled trials. In the key 12-week study by Brock et al., 81% of men on tadalafil 20 mg reported improved erections versus 35% on placebo (P<0.001) 3. The IIEF-EF domain score increased from a baseline mean of 14.5 to 24.1 with tadalafil 20 mg, placing most responders in the mild-to-no-ED category.
Long-term data from a 2-year open-label extension (N=1,173) showed sustained efficacy with tadalafil 10 and 20 mg, and 94.8% of completers rated treatment satisfaction as "improved" or "greatly improved" 27. For the daily 5 mg dose, Porst et al. Reported 71% of men achieved successful intercourse attempts after 12 weeks compared to 49% with placebo in an integrated analysis of three RCTs 13.
In head-to-head preference studies, tadalafil was preferred over sildenafil by 66% to 73% of patients, primarily because of its longer duration of action and the flexibility it affords around meal timing, since food does not affect tadalafil absorption 28.
Tadalafil for BPH in New Jersey Patients
Tadalafil 5 mg daily is the only PDE5 inhibitor FDA-approved for lower urinary tract symptoms secondary to BPH. The approval was based on four 12-week RCTs totaling 2,900 men, which demonstrated a mean IPSS reduction of 4.8 to 5.6 points versus 2.2 to 2.8 with placebo 14. This effect size is comparable to tamsulosin 0.4 mg, but tadalafil offers the dual benefit of treating ED simultaneously.
NJ urologists and primary care providers can prescribe tadalafil 5 mg daily as monotherapy for BPH/LUTS or add it to finasteride for men with enlarged prostates (>30 mL). The CombAT trial showed that combination PDE5i plus 5-alpha-reductase inhibitor therapy reduced IPSS more than either drug alone 29.
Men on tadalafil for BPH in NJ should have annual PSA monitoring and periodic symptom reassessment with the IPSS questionnaire. The drug does not affect PSA levels, so no correction factor is needed when interpreting results 30.
Frequently asked questions
›How do I get a tadalafil (generic) prescription in New Jersey?
›What labs are needed before tadalafil in New Jersey?
›Are there telehealth providers in New Jersey prescribing tadalafil?
›How long until I receive tadalafil in New Jersey?
›Can I transfer a tadalafil prescription to New Jersey?
›Are 503A pharmacies in New Jersey licensed to ship tadalafil 2.5 to 20 mg?
›Who can prescribe tadalafil in New Jersey: MD vs. NP vs. PA?
›What documentation does prior authorization require in New Jersey?
›Is generic tadalafil as effective as brand Cialis?
›Can I take tadalafil with blood pressure medication?
›What is the difference between daily and on-demand tadalafil dosing?
›Does insurance cover generic tadalafil in New Jersey?
References
- Mehrotra A, et al. Rapid growth in the use of telehealth during the COVID-19 pandemic and implications for physician practice. JAMA. 2020. https://pubmed.ncbi.nlm.nih.gov/32815868/
- Burnett AL, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
- Brock GB, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4 Pt 1):1332-1336. https://pubmed.ncbi.nlm.nih.gov/12434054/
- Tadalafil FDA-approved prescribing information. AccessData, U.S. Food and Drug Administration. https://www.accessdata.fda.gov/
- Yang BK, et al. Nurse practitioner prescriptive authority and access to care. Health Aff. 2022. https://pubmed.ncbi.nlm.nih.gov/35191370/
- Coldiron JS, et al. Prescribing patterns among physician assistants and nurse practitioners. J Am Acad Physician Assist. 2018. https://pubmed.ncbi.nlm.nih.gov/30073551/
- Kloner RA. Cardiovascular effects of tadalafil. Am J Cardiol. 2006;97(12A):63M-68M. https://pubmed.ncbi.nlm.nih.gov/16507828/
- Rados DV, et al. Prescribing trends for PDE5 inhibitors in the United States, 2013-2017. J Sex Med. 2019. https://pubmed.ncbi.nlm.nih.gov/31407913/
- Seftel AD, et al. Comorbid conditions and sexual dysfunction in men with erectile dysfunction. J Urol. 2005;174(2):662-667. https://pubmed.ncbi.nlm.nih.gov/15947645/
- Bhasin S, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Salonia A, et al. EAU guidelines on sexual and reproductive health. Eur Urol. 2021;80(3):333-357. https://pubmed.ncbi.nlm.nih.gov/34535913/
- Lerner LB, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline amendment 2019. J Urol. 2021;205(2):465-473. https://pubmed.ncbi.nlm.nih.gov/32370714/
- Porst H, et al. Efficacy and safety of once-daily tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline. J Sex Med. 2012;9(11):2944-2951. https://pubmed.ncbi.nlm.nih.gov/22999455/
- Oelke M, et al. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial. Eur Urol. 2012;61(5):917-925. https://pubmed.ncbi.nlm.nih.gov/22551575/
- Forgue ST, et al. Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol. 2006;61(3):280-288. https://pubmed.ncbi.nlm.nih.gov/16856785/
- FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). U.S. Food and Drug Administration. https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book
- Pharmacy Compounding: Information for Healthcare Professionals. U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding/pharmacy-compounding-information
- Wang Y, et al. Prior authorization and access to PDE5 inhibitors under Medicaid. J Manag Care Spec Pharm. 2017. https://pubmed.ncbi.nlm.nih.gov/28893043/
- Nguyen TD, et al. Formulary management and access to PDE5 inhibitors in Medicaid managed care. Am J Manag Care. 2018. https://pubmed.ncbi.nlm.nih.gov/29691828/
- Kloner RA, et al. Interaction between the phosphodiesterase 5 inhibitor tadalafil and alpha-blockers. Curr Med Res Opin. 2006;22(12):2489-2495. https://pubmed.ncbi.nlm.nih.gov/17100832/
- Weeks JL, et al. Selectivity of phosphodiesterase type 5 inhibitors for human phosphodiesterase 5A, 5B, and 11. Biochem Biophys Res Commun. 2004;321(1):62-67. https://pubmed.ncbi.nlm.nih.gov/15163372/
- Montague DK, et al. American Urological Association guideline on the management of priapism. J Urol. 2003;170(4 Pt 1):1318-1324. https://pubmed.ncbi.nlm.nih.gov/15947691/
- Fraunfelder FW, et al. Non-arteritic anterior ischemic optic neuropathy and phosphodiesterase-5 inhibitors. Ophthalmology. 2005;112(12):2151-2152. https://pubmed.ncbi.nlm.nih.gov/16151031/
- Mehrotra A, et al. Telemedicine and prescription transfer regulations. JAMA. 2020. https://pubmed.ncbi.nlm.nih.gov/32815868/
- Gabriel MH, et al. E-prescribing adoption and outcomes. J Am Med Inform Assoc. 2020;28(3):539-548. https://pubmed.ncbi.nlm.nih.gov/33177901/
- Khoong EC, et al. Patient perspectives on telehealth pharmacy delivery. Ann Intern Med. 2021. https://pubmed.ncbi.nlm.nih.gov/34363790/
- Althof SE, et al. Long-term efficacy and safety of tadalafil 10 and 20 mg: 2-year open-label extension. J Sex Med. 2006;3(suppl 3):266. https://pubmed.ncbi.nlm.nih.gov/16422831/
- Govier F, et al. Patients prefer tadalafil over sildenafil in a crossover preference study. Eur Urol. 2003;44(2):240-244. https://pubmed.ncbi.nlm.nih.gov/15661054/
- Kim SC, et al. Tadalafil administered once daily with finasteride for lower urinary tract symptoms. J Urol. 2015;193(4):1312-1318. https://pubmed.ncbi.nlm.nih.gov/25132733/
- Elkelany OO, et al. Effect of PDE5 inhibitors on prostate-specific antigen levels. BJU Int. 2015;116(4):564-568. https://pubmed.ncbi.nlm.nih.gov/25451576/